DIALYSIS GUIDELINES
CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence and effectiveness.
| DIALYSIS GUIDELINES | Status |
|---|---|
| Biochemical and Haematological Targets | Jan 2012 Jul 2013 |
| Dialysis Adequacy | Apr 2013 |
| Infection Control for Haemodialysis Units | Nov 2018 |
| Peritonitis Treatment and Prophylaxis | Jan 2014 |
| Vascular Access | June 2012 |
All Guidelines published more than 5 years ago have been moved to Archived Guidelines.
| GUIDELINE SUMMARIES |
|---|
| KHA-CARI guideline: Biochemical and haematological targets: Haemoglobin concentrations in patients using erythropoietin-stimulating agents. McMahon LP, Macginley R. Nephrology 2012; 17(1): 17-9. |
| KHA-CARI Guideline: Use of iron in chronic kidney disease patients. MacGinley R, Walker R, Irving M. Nephrology 2013; 18(12): 747-9. |
Readers of these guidelines are advised to also refer to the guidelines contained in the “Vitamin D, Calcimimetics and Phosphate Binders” (Chronic Kidney Disease) section.
| DIALYSIS GUIDELINES | Status |
|---|---|
| Biochemical and Haematological Targets | Jan 2012 Jul 2013 |
| Dialysis Adequacy | Apr 2013 |
| Infection Control for Haemodialysis Units | Nov 2018 |
| Peritonitis Treatment and Prophylaxis | Jan 2014 |
| Vascular Access | June 2012 |
All Guidelines published more than 5 years ago have been moved to Archived Guidelines.
| GUIDELINE SUMMARIES |
|---|
| KHA-CARI guideline: Biochemical and haematological targets: Haemoglobin concentrations in patients using erythropoietin-stimulating agents. McMahon LP, Macginley R. Nephrology 2012; 17(1): 17-9. |
| KHA-CARI Guideline: Use of iron in chronic kidney disease patients. MacGinley R, Walker R, Irving M. Nephrology 2013; 18(12): 747-9. |
Readers of these guidelines are advised to also refer to the guidelines contained in the “Vitamin D, Calcimimetics and Phosphate Binders” (Chronic Kidney Disease) section.